Non-Alcoholic Fatty Liver Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been found to have fat buildup in the liver, confirmed by ultrasound, MRI, or a special measurement tool called a Controlled Attenuation Parameter
- People whose liver fat is not caused by certain medications (such as steroids, methotrexate, amiodarone, or tamoxifen)
- People who do not drink alcohol heavily (less than 210 grams per week for men, or less than 140 grams per week for women)
- People whose liver condition is not caused by another known liver disease, such as hepatitis B or C, hemochromatosis, autoimmune hepatitis, or several other specific liver conditions (confirm with trial site for the full list)
- People aged 18 to 80 years old
- People who are enrolled in the French social security system (confirm with trial site if this applies outside France)
- People who have given written agreement to take part and follow the study procedures
Who may not be able to join:
- People whose liver disease has reached an advanced, unstable stage causing complications such as fluid buildup in the abdomen, internal bleeding, confusion caused by liver failure, or kidney problems related to liver disease
- People who have liver cancer
- People for whom having a liver biopsy (a small tissue sample taken from the liver) would not be safe
- People who are currently taking part in, or have recently taken part in, another clinical trial involving an experimental drug (within the past month)
- People who are pregnant, breastfeeding, or have recently given birth
- People who are under a court or government-issued restriction that would affect their ability to participate
- People receiving involuntary psychiatric treatment
- People who are under a legal protection order
- People who are not able to give their own informed consent
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +33241353410
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Rate of patients correctly classified for advanced liver fibrosis
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.